Price target
2.250.000.00%
The 5 analysts offering 1 year price forecasts for PHGN have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to PHGN in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PHGN EPS for the last quarter is −0.00 CHF despite the estimation of −0.00 CHF. In the next quarter EPS is expected to reach 0.00 CHF. Track more of PHARMING GROUP NV financials and stay on top of what is up with the company.
In the next quarter PHARMING GROUP NV revenue is expected to reach 73.79 M CHF. Check out PHARMING GROUP NV revenue and earnings and make informed decisions.
According to analysts, PHGN price target is 2.25 CHF with a max estimate of 3.39 CHF and a min estimate of 1.35 CHF. Check if this forecast comes true in a year, meanwhile watch PHARMING GROUP NV stock price chart and keep track of the current situation with PHGN news and stock market news.
We've gathered opinions of 5 analysts rating PHGN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.